POC-MD MRI-based Trial in Relapsing-remitting Multiple Scler

Summary

A randomized, multi-center, double-blind, proof-of-concept study to assess the effect of multiple infusions of AIN457 (10 mg/kg) versus placebo on disease activity as measured by MRI scans over a 24 week period in patients with relapsing-remitting multiple sclerosis

Timeline

Start

2009-12

Primary completion

2012-04

Completion

2012-04

Drugs

Indications